ResMed Acquires VirtuOx to Expand Virtual Care and At-Home Diagnostics

ResMed has acquired VirtuOx, a leading independent diagnostic testing facility specializing in sleep, respiratory, and cardiac conditions, to enhance its virtual care offerings and streamline the diagnostic process for patients and providers. The acquisition aims to improve early access to diagnosis, reduce delays in care, and strengthen ResMed’s digital ecosystem for managing sleep-disordered breathing and related conditions.

VirtuOx’s platform provides fast, flexible, and affordable at-home testing, addressing common barriers to diagnosis—especially for conditions like obstructive sleep apnea. By integrating VirtuOx into its operations, ResMed seeks to create a more connected and efficient care pathway, from evaluation through treatment.

ResMed stated that the deal will help expand into adjacent health areas like insomnia and deepen partnerships with physicians, sleep labs, and home medical equipment providers. VirtuOx will continue to operate under its own brand, with its leadership team remaining in place.

Financial terms were not disclosed, as the transaction is not considered material to ResMed’s financial results.